Quick Answer
GENMAB A/S reported Total Assets of $12.87 billion for fiscal year 2025.
GENMAB A/S — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Total Assets | $12.87B -71.9% |
$45.81B +29.8% |
$35.29B | $15.14B +79.0% |
$8.46B | — |
| R&D Expense | $1.61B +13.6% |
$1.41B +27.7% |
$1.11B | $2.39B +66.7% |
$1.43B +63.7% |
$874.00M |
- GENMAB A/S reported Total Assets of $12.87 billion for fiscal year 2025.
- GENMAB A/S showed a decrease of -71.9% in Total Assets compared to the prior fiscal year.
- GENMAB A/S reported R&D Expense of $1.61 billion for fiscal year 2025.
- GENMAB A/S showed an increase of +13.6% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: